144 related articles for article (PubMed ID: 31448872)
1. Platelet-type von Willebrand disease: Local disorder of the platelet GPIbα β-switch drives high-affinity binding to von Willebrand factor.
Tischer A; Machha VR; Moon-Tasson L; Auton M
J Thromb Haemost; 2019 Dec; 17(12):2022-2034. PubMed ID: 31448872
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations.
Dumas JJ; Kumar R; McDonagh T; Sullivan F; Stahl ML; Somers WS; Mosyak L
J Biol Chem; 2004 May; 279(22):23327-34. PubMed ID: 15039442
[TBL] [Abstract][Full Text] [Related]
3. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
[TBL] [Abstract][Full Text] [Related]
4. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
Miura S; Li CQ; Cao Z; Wang H; Wardell MR; Sadler JE
J Biol Chem; 2000 Mar; 275(11):7539-46. PubMed ID: 10713059
[TBL] [Abstract][Full Text] [Related]
5. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping.
Tischer A; Machha VR; Frontroth JP; Brehm MA; Obser T; Schneppenheim R; Mayne L; Walter Englander S; Auton M
J Mol Biol; 2017 Jul; 429(14):2161-2177. PubMed ID: 28533135
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of GPIbalpha-vWF-A1 tether bond under flow: effect of GPIbalpha mutations on the association and dissociation rates.
Kumar RA; Dong JF; Thaggard JA; Cruz MA; López JA; McIntire LV
Biophys J; 2003 Dec; 85(6):4099-109. PubMed ID: 14645097
[TBL] [Abstract][Full Text] [Related]
8. A mechanism for localized dynamics-driven affinity regulation of the binding of von Willebrand factor to platelet glycoprotein Ibα.
Liu G; Fang Y; Wu J
J Biol Chem; 2013 Sep; 288(37):26658-67. PubMed ID: 23902764
[TBL] [Abstract][Full Text] [Related]
9. A p.Arg127Gln variant in GPIbα LRR5 allosterically enhances affinity for VWF: a novel form of platelet-type VWD.
Bury L; Falcinelli E; Kuchi Bhotla H; Mezzasoma AM; Guglielmini G; Tischer A; Moon-Tasson L; Auton M; Gresele P
Blood Adv; 2022 Apr; 6(7):2236-2246. PubMed ID: 34619770
[TBL] [Abstract][Full Text] [Related]
10. Force-induced on-rate switching and modulation by mutations in gain-of-function von Willebrand diseases.
Kim J; Hudson NE; Springer TA
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4648-53. PubMed ID: 25810255
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val.
Doggett TA; Girdhar G; Lawshe A; Miller JL; Laurenzi IJ; Diamond SL; Diacovo TG
Blood; 2003 Jul; 102(1):152-60. PubMed ID: 12637314
[TBL] [Abstract][Full Text] [Related]
12. Phenotype changes resulting in high-affinity binding of von Willebrand factor to recombinant glycoprotein Ib-IX: analysis of the platelet-type von Willebrand disease mutations.
Tait AS; Cranmer SL; Jackson SP; Dawes IW; Chong BH
Blood; 2001 Sep; 98(6):1812-8. PubMed ID: 11535515
[TBL] [Abstract][Full Text] [Related]
13. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain.
Huizinga EG; Tsuji S; Romijn RA; Schiphorst ME; de Groot PG; Sixma JJ; Gros P
Science; 2002 Aug; 297(5584):1176-9. PubMed ID: 12183630
[TBL] [Abstract][Full Text] [Related]
14. Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway.
Bury L; Falcinelli E; Mezzasoma AM; Guglielmini G; Momi S; Gresele P
Haematologica; 2022 Jul; 107(7):1643-1654. PubMed ID: 34407603
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of regulation of von Willebrand factor binding to glycoprotein Ib.
Blenner MA; Dong X; Springer TA
J Biol Chem; 2014 Feb; 289(9):5565-79. PubMed ID: 24391089
[TBL] [Abstract][Full Text] [Related]
16. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
Ju L; Dong JF; Cruz MA; Zhu C
J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of VWF-mediated platelet GPIbalpha binding.
Auton M; Zhu C; Cruz MA
Biophys J; 2010 Aug; 99(4):1192-201. PubMed ID: 20713003
[TBL] [Abstract][Full Text] [Related]
18. Changes in thermodynamic stability of von Willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha.
Auton M; Sedlák E; Marek J; Wu T; Zhu C; Cruz MA
Biophys J; 2009 Jul; 97(2):618-27. PubMed ID: 19619477
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease.
Matsubara Y; Murata M; Sugita K; Ikeda Y
J Thromb Haemost; 2003 Oct; 1(10):2198-205. PubMed ID: 14521605
[TBL] [Abstract][Full Text] [Related]
20. The Von Willebrand Factor A1-Collagen III Interaction Is Independent of Conformation and Type 2 Von Willebrand Disease Phenotype.
Machha VR; Tischer A; Moon-Tasson L; Auton M
J Mol Biol; 2017 Jan; 429(1):32-47. PubMed ID: 27889474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
